FLUCILONE Cream - Lomus Pharmaceuticals Pvt. Ltd.

FLUCILONE Cream/Plus
Dosage Forms/Composition
Cream: Fluocinolone Acetonide 0.025 % w/w.
Plus: Fluocinolone Acetonide 0.01 % w/w.
Pharmacological Index
Corticosteroid
INDICATION
Steroid responsive dermatoses, seborrheic dermatitis of the scalp, scalp psoriasis.
Pregnancy Risk Factor
C
Contraindications
Fungal infection, hypersensitivity to fluocinolone or any component, TB of skin, herpes
(including varicella).
Warnings/Precautions
Adverse systemic effects may occur when used on large areas of the body, denuded
areas, for prolonged periods of time, with an occlusive dressing, and/or in infants or
small children. Infants and small children may be more susceptible to adrenal axis
suppression from topical corticosteroid therapy.
Adverse Reactions

Metabolism: Primarily in the skin; small amount absorbed into systemic circulation is
metabolized primarily in the liver to inactive compounds
Elimination: By the kidneys primarily as glucuronides and sulfate, but also as
unconjugated products; small amounts of metabolites are excreted in feces
Usual Dosage
Children and Adults: Topical: Apply a thin layer to affected area 2-4 times/day. Therapy
should be discontinued when control is achieved; if no improvement is seen,
reassessment of diagnosis may be necessary.
Patient Information
A thin film of cream or ointment is effective; do not overuse; do not use tight-fitting
diapers or plastic pants on children being treated in the diaper area; use only as
prescribed, and for no longer than the period prescribed; apply sparingly in light film;
rub in lightly; avoid contact with eyes; notify physician if condition being treated
persists or worsens.
LOMUS Drug Information Center
Lomus Pharmaceuticals Pvt. Ltd.
P.O. Box No 4506, Lomus House (Corporate office),
Kailash Chour, Lazimpat, Kathmandu, Nepal
Ph: 4436396 (Hunting Line). Fx: 977-1-4436395
E-mail: druginfo@lomus.com.np